ProfileGDS4459 / ENSG00000213533
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 57% 69% 73% 57% 63% 63% 69% 74% 69% 76% 60% 72% 69% 60% 77% 72% 65% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.6857
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.1769
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.6373
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.7457
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.9563
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.9163
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.3969
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.6474
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.3469
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.8276
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.6760
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.5872
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.2969
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.7760
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.0177
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.2972
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.9565